Patents by Inventor Oliver Martin

Oliver Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110003778
    Abstract: The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometriosis which has a more favorable activity and side-effect profile than treatment therapies currently available. Using a mineralocorticoid receptor antagonist, it is possible to threat endometriosis permanently without any loss of bone mass.
    Type: Application
    Filed: February 28, 2008
    Publication date: January 6, 2011
    Applicant: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Carsten Moeller, Ulrike Kaufmann-Reiche, Anja Schmidt, Ulrike Fuhrmann, Oliver-Martin Fischer
  • Publication number: 20080116272
    Abstract: The invention relates to a luminescent security feature system, a substrate having said luminescent security feature, and an apparatus and method for checking the luminescent security feature. The invention is characterized in that, among other things, the security feature comprises at least two luminescent materials which produce corresponding, overlapping emission peaks in response to an excitation radiation.
    Type: Application
    Filed: September 1, 2005
    Publication date: May 22, 2008
    Inventors: Thomas Giering, Gerhard Schwenk, Wolfgang Rauscher, Oliver Martin, Yannick Mechine, Lysis Cubieres
  • Publication number: 20060148678
    Abstract: The invention relates to the field of chemistry and more specifically to the field of medicinal chemistry. The invention is directed to N-acyl-dipeptide-like compounds having the general formula I wherein substituents A, B, X, Y, R1, R2, and subscripts n, m, p and q have the same meanings as those given in the claims. The invention is equally directed to pharmaceutical compositions containing as an active ingredient at least one compound of general formula I either in acid or salt form with an organic or mineral base. The compounds persuant to the invention display interesting pharmacological properties which make them useful as drugs.
    Type: Application
    Filed: February 28, 2006
    Publication date: July 6, 2006
    Inventors: Jacques Bauer, Oliver Martin
  • Patent number: 5271075
    Abstract: This invention relates to a remotely optically powered fiber optic switch, e.g. in a fiber optic network, and a GRIN-rod (Graded-Refractive-Index-rod) lens with integrated planar mirror as a switching element, in particular suited for fiber optic switches. A distribution panel, in which the switching element, a wavelength-division demultiplexer, a light-into-current converter, and an actuator for the switching element are situated, is remotely optically powered from a station in the network. Part of this station is a laser diode which feeds a powering lightwave via a wavelength-division multiplexer into an optical fiber interconnecting the station with the distribution panel, which fiber can also be used for data transmission. The light-into-current converter receives the powering lightwave and generates an electric current for driving the actuator and moving the switching element.
    Type: Grant
    Filed: March 17, 1992
    Date of Patent: December 14, 1993
    Assignee: International Business Machines Corporation
    Inventors: Fritz Gfeller, Peter L. Heinzmann, Oliver Martin, Johann R. Mueller